Young David
SEC CIK 1378166 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | Pres. Research, Development, Dir, 10% | 21.7K | $306.1K | — | 27 | 2021-08-05 | 2026-06-30 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:16 | 2026-06-30 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $1.93 | +2,531 | 21.7K | +13% | +$4,885 | |
| 2026-06-16 16:24 | 2026-06-15 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.22 | +2,067 | 19.2K | +12% | +$4,589 | |
| 2026-06-01 17:01 | 2026-05-29 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.57 | +1,786 | 17.1K | +12% | +$4,590 | |
| 2026-05-19 18:04 | 2026-05-15 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.97 | +1,545 | 15.3K | +11% | +$4,589 | |
| 2026-05-01 16:39 | 2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.69 | +1,706 | 13.8K | +14% | +$4,589 | |
| 2026-04-17 16:55 | 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.97 | +1,545 | 12.1K | +15% | +$4,589 | |
| 2026-04-01 17:20 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.54 | +1,810 | 10.6K | +21% | +$4,588 | |
| D | 2026-02-04 | 2026-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | M - OptEx | $0.00 | +49 | 8,752 | +0.6% | $0 |
| 2025-04-11 | 2025-04-01 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | F - Tax | $0.41 | -5,345 | 217.3K | -2% | -$2,191 | |
| 2025-04-11 | 2025-04-01 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | M - OptEx | — | +17.3K | 222.7K | +8% | — | |
| 2025-01-29 | 2025-01-27 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $0.8 | +124.5K | 205.4K | +154% | +$99.6K | |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | M - OptEx | — | +2,319 | 81.2K | +3% | — |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | F - Tax | $2.41 | -800 | 80.5K | -1.0% | -$1,927 |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | F - Tax | $2.79 | -518 | 80.5K | -0.6% | -$1,445 |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | M - OptEx | — | +1,675 | 81.1K | +2% | — |
| 2024-02-08 | 2024-02-07 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.45 | +21.0K | 79.4K | +36% | +$51.5K | |
| 2024-02-07 | 2024-02-06 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir | P - Purchase | $2.53 | +20.0K | 58.4K | +52% | +$50.6K | |
| 2023-10-12 | 2023-10-12 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir, 10% | A - Grant | $0.29 | +155.3K | 767.7K | +25% | +$45.0K | |
| 2023-10-10 | 2023-10-10 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres. Research, Development, Dir, 10% | A - Grant | $0.24 | +142.0K | 612.4K | +30% | +$34.1K | |
| 2023-06-12 | 2023-06-12 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres, CEO, Dir, 10% | P - Purchase | $0.8 | +40.0K | 470.4K | +9% | +$32.0K | |
| 2023-04-14 | 2023-04-14 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres, CEO, Dir, 10% | P - Purchase | $0.55 | +20.0K | 430.4K | +5% | +$11.0K | |
| M | 2023-04-13 | 2023-04-11+ | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres, CEO, Dir, 10% | P - Purchase | $0.4833 | +60.0K | 410.4K | +17% | +$29.0K |
| 2023-02-10 | 2023-02-09 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres, CEO, Dir, 10% | A - Grant | $0.8 | +18.8K | 350.4K | +6% | +$15.0K | |
| 2022-08-23 | 2022-08-16 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres, CEO, Dir, 10% | G - Gift | $0.00 | -9,250 | 377.8K | -2% | $0 | |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres, CEO, Dir, 10% | M - OptEx | — | +7,601 | 389.6K | +2% | — | |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres, CEO, Dir, 10% | F - Tax | $3.17 | -2,531 | 387.0K | -0.6% | -$8,023 | |
| 2021-08-09 | 2021-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Young David | CEO, Dir, 10% | A - Grant | — | +7,601 | 382.0K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations